The team at Cory Watson Attorneys represents Abilify patients from across the U.S. The plaintiffs contend the maker of Abilify failed to warn of
The makers of Abilify hid evidence from the government when they received FDA approval for the drug. The makers of Abilifys failed to warn
This is the video for Abilify for Bipolar Disorder. All copyrights go to the makers of Abilify.
The makers of Abilify Maintena, Abilify Mycite, Jynarque, Rexulti, and Samsca have a patient assistance program to help with general questions, access to
This is the video for Abilify for Bipolar Disorder. All copyrights go to the makers of Abilify.
The Abilify lawsuit claims the makers of Abilify failed to warn doctors and patients that the drug could cause compulsive gambling, shopping, eating, and sex.
The Abilify lawsuit claims the makers of Abilify failed to warn doctors and patients that the drug could cause compulsive gambling, shopping, eating, and sex.
In patent litigation between the maker of Abilify and a potential competing generic, the generic maker stated a monopolization counterclaim
Otsuka Pharmaceutical and Bristol-Myers Squibb, the makers of Abilify, are accused of negligently designing Abilify and hiding evidence that the drug increases
Comments
Well done!